Cargando…
Discovery of JAK2/3 Inhibitors from Quinoxalinone-Containing Compounds
[Image: see text] Janus kinases (JAKs) are involved in a wide variety of cell signaling associated with T-cell and B-cell mediated diseases. The pathogenesis of common lymphoid-derived diseases and leukemia cancer has been implicated in JAK2 and JAK3. Therefore, to decrease the risk of these disease...
Autores principales: | Sanachai, Kamonpan, Mahalapbutr, Panupong, Tabtimmai, Lueacha, Seetaha, Supaphorn, Kittikool, Tanakorn, Yotphan, Sirilata, Choowongkomon, Kiattawee, Rungrotmongkol, Thanyada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494680/ https://www.ncbi.nlm.nih.gov/pubmed/36157733 http://dx.doi.org/10.1021/acsomega.2c04769 |
Ejemplares similares
-
Pharmacophore-Based
Virtual Screening and Experimental
Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
In Silico and In Vitro Study of Janus Kinases Inhibitors from Naphthoquinones
por: Sanachai, Kamonpan, et al.
Publicado: (2023) -
Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights
por: Suriya, Utid, et al.
Publicado: (2022) -
Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies
por: Aiebchun, Thitinan, et al.
Publicado: (2021) -
Biological Evaluation and Molecular Dynamics Simulation of Chalcone Derivatives as Epidermal Growth Factor-Tyrosine Kinase Inhibitors
por: Sangpheak, Kanyani, et al.
Publicado: (2019)